Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Acura Pharmaceuticals, Inc.
organization5 mentionslast seen Nov 9, 2026
Pharmaceutical company developing opioid products with abuse-deterrent technologies.
Relationships 9
- Acura Pharmaceuticals, Inc.employsRobert A. Seiser99% confidence2 sources
- Acura Pharmaceuticals, Inc.developsLTX-0398% confidence2 sources
- Acura Pharmaceuticals, Inc.developsImpede97% confidence2 sources
- Acura Pharmaceuticals, Inc.developsLIMITx97% confidence2 sources
- Acura Pharmaceuticals, Inc.funded byAbuse Deterrent Pharma, LLC95% confidence1 source
- Acura Pharmaceuticals, Inc.developsAcura NEXERA Vision90% confidence1 source
- Acura Pharmaceuticals, Inc.developsAcura MDX Type S85% confidence1 source
- Los Angeles Auto Showpartners withAcura Pharmaceuticals, Inc.85% confidence1 source
- Abuse Deterrent Pharma, LLCsuppliesAcura Pharmaceuticals, Inc.50% confidence1 source
Relationship
Acura Pharmaceuticals, Inc.developsImpede
97% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARNov 3, 2026ACURA PHARMACEUTICALS, INC 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Item 9.01: Financial Statements and Exhibits
the development of our products utilizing our LIMITx™ and Impede® technologies
- filingSEC EDGAROct 6, 2026ACURA PHARMACEUTICALS, INC 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.01: Completion of Acquisition or Disposition of Assets; Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Item 9.01: Financial Statements and Exhibits
our products utilizing our LIMITx™ and Impede® technologies